May 8 Financial Quick Takes: Trevi IPO, BMS, GeneQuantum

Trevi prices $55M IPO below range
Trevi Therapeutics Inc. (NASDAQ:TRVI) shares gained back some ground Wednesday -- adding $0.34 to $8.23 for the day -- after

Read the full 251 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE